678 related articles for article (PubMed ID: 26654216)
1. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
3. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
4. Pluripotent Conversion of Muscle Stem Cells Without Reprogramming Factors or Small Molecules.
Bose B; Shenoy P S
Stem Cell Rev Rep; 2016 Feb; 12(1):73-89. PubMed ID: 26358783
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions.
Slamecka J; Laurini J; Shirley T; Hoerstrup SP; Weber B; Owen L; McClellan S
J Vis Exp; 2017 Nov; (129):. PubMed ID: 29286443
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.
Velasquez-Mao AJ; Tsao CJM; Monroe MN; Legras X; Bissig-Choisat B; Bissig KD; Ruano R; Jacot JG
PLoS One; 2017; 12(5):e0177824. PubMed ID: 28545044
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach.
Moschidou D; Mukherjee S; Blundell MP; Drews K; Jones GN; Abdulrazzak H; Nowakowska B; Phoolchund A; Lay K; Ramasamy TS; Cananzi M; Nettersheim D; Sullivan M; Frost J; Moore G; Vermeesch JR; Fisk NM; Thrasher AJ; Atala A; Adjaye J; Schorle H; De Coppi P; Guillot PV
Mol Ther; 2012 Oct; 20(10):1953-67. PubMed ID: 22760542
[TBL] [Abstract][Full Text] [Related]
8. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics.
Moschidou D; Mukherjee S; Blundell MP; Jones GN; Atala AJ; Thrasher AJ; Fisk NM; De Coppi P; Guillot PV
Stem Cells Dev; 2013 Feb; 22(3):444-58. PubMed ID: 23050522
[TBL] [Abstract][Full Text] [Related]
9. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
10. Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem Cells.
Kimura K; Tsukamoto M; Tanaka M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Sugiura K; Hatoya S
Stem Cells Dev; 2021 Jan; 30(2):79-90. PubMed ID: 33256572
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Reprogramming Efficiency and Pluripotency of the Established Human iPSCS by Pluripotency Markers.
Cevallos RR; Hossain ME; Zhang R; Hu K
Methods Mol Biol; 2021; 2239():235-249. PubMed ID: 33226623
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
[TBL] [Abstract][Full Text] [Related]
13. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
[TBL] [Abstract][Full Text] [Related]
14. Generation of transgene-free porcine intermediate type induced pluripotent stem cells.
Li D; Secher J; Hyttel P; Ivask M; Kolko M; Hall VJ; Freude KK
Cell Cycle; 2018; 17(23):2547-2563. PubMed ID: 30457474
[TBL] [Abstract][Full Text] [Related]
15. Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions.
Wang Y; Chou BK; Dowey S; He C; Gerecht S; Cheng L
Stem Cell Res; 2013 Nov; 11(3):1103-16. PubMed ID: 23973800
[TBL] [Abstract][Full Text] [Related]
16. Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig.
Park JK; Kim HS; Uh KJ; Choi KH; Kim HM; Lee T; Yang BC; Kim HJ; Ka HH; Kim H; Lee CK
PLoS One; 2013; 8(1):e52481. PubMed ID: 23326334
[TBL] [Abstract][Full Text] [Related]
17. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
[TBL] [Abstract][Full Text] [Related]
18. Inducing Pluripotency in the Domestic Cat (
Dutton LC; Dudhia J; Guest DJ; Connolly DJ
Stem Cells Dev; 2019 Oct; 28(19):1299-1309. PubMed ID: 31389301
[TBL] [Abstract][Full Text] [Related]
19. Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.
Im I; Son YS; Jung KB; Kang I; Teh BE; Lee KB; Son MY; Kim J
J Biol Chem; 2019 Dec; 294(49):18547-18556. PubMed ID: 31570522
[TBL] [Abstract][Full Text] [Related]
20. iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin.
Yan X; Qin H; Qu C; Tuan RS; Shi S; Huang GT
Stem Cells Dev; 2010 Apr; 19(4):469-80. PubMed ID: 19795982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
